{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:11:26Z","timestamp":1784329886510,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.diabres.2013.07.009","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T22:54:00Z","timestamp":1376088840000},"page":"65-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Impact of low-density lipoprotein cholesterol on cardiovascular outcomes in people with type 2 diabetes: A meta-analysis of prospective cohort studies"],"prefix":"10.1016","volume":"102","author":[{"given":"Yujie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Lammi-Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2013.07.009_bib0005","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes \u2013 2013","volume":"36","author":"Amer Diabet","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.07.009_bib0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2013.07.009_bib0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diabres.2010.01.026","article-title":"Global healthcare expenditure on diabetes for 2010 and 2030","volume":"87","author":"Zhang","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2013.07.009_bib0020","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2013.07.009_bib0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/diacare.22.2.233","article-title":"The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years","volume":"22","author":"Coutinho","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.07.009_bib0030","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.48.5.937","article-title":"Hyperglycemia and cardiovascular disease in type 2 diabetes","volume":"48","author":"Laakso","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2013.07.009_bib0035","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2105\/AJPH.81.9.1158","article-title":"Cause-specific mortality in a population-based study of diabetes","volume":"81","author":"Moss","year":"1991","journal-title":"Am J Public Health"},{"key":"10.1016\/j.diabres.2013.07.009_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/diacare.26.1.16","article-title":"Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes \u2013 the Strong Heart Study","volume":"26","author":"Lu","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.07.009_bib0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/dmr.5610030206","article-title":"Diabetes and atherosclerosis: an epidemiologic view","volume":"3","author":"Pyorala","year":"1987","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.diabres.2013.07.009_bib0050","first-page":"1364","article-title":"The relationship between serum LDL-cholesterol, HDL-cholesterol and systolic blood pressure in patients with type 2 diabetes","volume":"64","author":"Nasri","year":"2006","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.diabres.2013.07.009_bib0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5001\/omj.2011.63","article-title":"The association between body mass index, lipid profile and serum estradiol levels in a sample of iraqi diabetic premenopausal women","volume":"26","author":"Ali","year":"2011","journal-title":"Oman Med J"},{"key":"10.1016\/j.diabres.2013.07.009_bib0060","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1995-7645(12)60080-7","article-title":"Association of glycosylated hemoglobin level with lipid ratio and individual lipids in type 2 diabetic patients","volume":"5","author":"Yan","year":"2012","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.diabres.2013.07.009_bib0065","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/bmj.38793.468449.AE","article-title":"Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials","volume":"332","author":"Costa","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2013.07.009_bib0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2013.07.009_bib0075","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"E. Expert Panel on Detection, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2013.07.009_bib0080","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","volume":"28","author":"Graham","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2013.07.009_bib0085","first-page":"88","article-title":"Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)","volume":"28","author":"Ryden","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2013.07.009_bib0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0272-6386(93)70104-7","article-title":"Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure","volume":"21","author":"Hannedouche","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2013.07.009_bib0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.diabres.2013.07.009_bib0100","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2013.07.009_bib0105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2013.07.009_bib0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1475-2840-9-77","article-title":"Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study","volume":"9","author":"Ting","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2013.07.009_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036298","article-title":"Quantitative methods in the review of epidemiologic literature","volume":"9","author":"Greenland","year":"1987","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.diabres.2013.07.009_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/sim.4780040103","article-title":"A measure to aid in the interpretation of published clinical trials","volume":"4","author":"Begg","year":"1985","journal-title":"Stat Med"},{"key":"10.1016\/j.diabres.2013.07.009_bib0125","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/01.CIR.88.4.1421","article-title":"Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes","volume":"88","author":"Laakso","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2013.07.009_bib0130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/diacare.19.5.486","article-title":"Evolution, risk factors, and prognostic implications of albuminuria in NIDDM","volume":"19","author":"Niskanen","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.07.009_bib0135","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.2337\/diab.46.8.1354","article-title":"Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM","volume":"46","author":"Lehto","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2013.07.009_bib0140","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bmj.316.7134.823","article-title":"Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)","volume":"316","author":"Turner","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2013.07.009_bib0145","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/diabetes.47.11.1786","article-title":"Microalbuminuria and coronary heart disease in NIDDM \u2013 an incidence study","volume":"47","author":"Mattock","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2013.07.009_bib0150","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2337\/diacare.27.8.1991","article-title":"Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes","volume":"27","author":"Jiang","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.07.009_bib0155","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00125-004-1593-2","article-title":"Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes","volume":"47","author":"Schulze","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2013.07.009_bib0160","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00125-006-0195-6","article-title":"Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study","volume":"49","author":"Bruno","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2013.07.009_bib0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2840-7-9","article-title":"Development and validation of a risk score for hospitalization for heart failure in patients with type 2 diabetes mellitus","volume":"7","author":"Yang","year":"2008","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2013.07.009_bib0170","doi-asserted-by":"crossref","first-page":"e8464","DOI":"10.1371\/journal.pone.0008464","article-title":"The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13)","volume":"4","author":"van Hateren","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2013.07.009_bib0175","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-511X-9-6","article-title":"Lipid measures for prediction of incident cardiovascular disease in diabetic and nondiabetic adults: results of the 8.6 years follow-up of a population based cohort study","volume":"9","author":"Tohidi","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.diabres.2013.07.009_bib0180","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2337\/dc11-0209","article-title":"Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes a report from the Swedish national diabetes register","volume":"34","author":"Eliasson","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.07.009_bib0185","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1210\/jc.2011-0622","article-title":"Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS)","volume":"96","author":"Sone","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2013.07.009_bib0190","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2337\/dc11-1412","article-title":"Comparison of various lipid variables as predictors of coronary heart disease in japanese men and women with type 2 diabetes subanalysis of the Japan diabetes complications study","volume":"35","author":"Sone","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.07.009_bib0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.2012.06480.x","article-title":"LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos","volume":"1254","author":"Badimon","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.diabres.2013.07.009_bib0200","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1472-8206.2009.00739.x","article-title":"Lipid modification in type 2 diabetes: the role of LDL and HDL","volume":"23","author":"Verges","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.diabres.2013.07.009_bib0205","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1046\/j.1432-1327.1998.2520378.x","article-title":"Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells","volume":"252","author":"Vidal","year":"1998","journal-title":"Eur J Biochem"},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2013.07.009_bib0210","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1160\/THS10-11-0717","article-title":"Update on lipids, inflammation and atherothrombosis","volume":"105","author":"Badimon","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.diabres.2013.07.009_bib0215","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/ATVBAHA.107.159327","article-title":"Role of smooth muscle cells in the initiation and early progression of atherosclerosis","volume":"28","author":"Doran","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2013.07.009_bib0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cvr\/cvm045","article-title":"Low-density lipoproteins impair migration of human coronary vascular smooth muscle cells and induce changes in the proteomic profile of myosin light chain","volume":"77","author":"Padro","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.diabres.2013.07.009_bib0225","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.2337\/diacare.26.5.1540","article-title":"Cell surface expression of LDL receptor is decreased in type 2 diabetic patients and is normalized by insulin therapy","volume":"26","author":"Duvillard","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.07.009_bib0230","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.CIR.82.2.495","article-title":"Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk","volume":"82","author":"Austin","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2013.07.009_bib0235","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2337\/diacare.13.2.153","article-title":"Management of dyslipidemia in NIDDM","volume":"13","author":"Garg","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.07.009_bib0240","doi-asserted-by":"crossref","first-page":"48i","DOI":"10.1016\/S0002-9149(02)02633-4","article-title":"How, when, and why to use apolipoprotein B in clinical practice","volume":"90","author":"Sniderman","year":"2002","journal-title":"Am J Cardiol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822713002672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822713002672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T19:25:24Z","timestamp":1563650724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822713002672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0168822713002672"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2013.07.009","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of low-density lipoprotein cholesterol on cardiovascular outcomes in people with type 2 diabetes: A meta-analysis of prospective cohort studies","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2013.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}